PLK1 and cancer: Thus, it is possible that blocking Plk1 function can, in addition to affecting the ability of cancer cells with unstable genomes to progress through mitosis, reduce the self-renewal capacity of cancer stem cells and in that way, increase the overall sensitivity of the cells to chemotherapy agents such as taxane and platinum derivatives.